Agenda

Return

C. 45

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	November 17, 2015

Contra

Costa

County

Subject:

Purchase Order with Qiagen, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 11/17/2015

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Mary N. Piepho, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Daniel Peddycord, 313-6712
cc:	T Scott N Rios

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: November 17, 2015
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent, on behalf of Health Services Department, to execute a blanket Purchase Order with Qiagen, Inc., in the amount of $300,000.00 to purchase Quantiferon collection blood tubes and test kits for the period December 1, 2015 to November 30, 2016.

FISCAL IMPACT:

Total cost of $300,000 is included in the fiscal year 2015-16 budget. Funds will come from both patient billing (private pay, MediCal, MediCare, etc.) and a $65,000 contract with Chevron Corp. to perform this testing for their employees.

BACKGROUND:

Qiagen Inc. has been used by the Health Services Department for over ten (10) years. Qiagen provides the reagents required for use with testing instruments in our Public Health Laboratory. The reagents are necessary for specimens to be tested for tuberculosis, both active and latent infections. The Quantiferon test is a specific blood test that detects TB antigen in the blood of patients who have been exposed to the tuberculosis organism. A positive test would alert the provider to provide treatment and alleviate disease in later years.

CONSEQUENCE OF NEGATIVE ACTION:

The consequences of negative actions would be that the health care system would not be able to detect TB antigen in those patients who have been exposed, resulting in higher health care cost when they develop disease in later years. The tests would then need to be conducted by outside labs at a greater cost to the County. Public Heath Lab also uses the reagents purchased from Qiagen to conduct similar testing for the Chevron Corporation which generates revenue for CCC. Without the reagents we would not be able to conduct the tests.

CHILDREN'S IMPACT STATEMENT:

Not applicable.